{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:06:14Z","timestamp":1790741174687,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is primarily characterized by insulin resistance, which leads to increased hepatic glucose production and impaired insulin-mediated glucose disposal. Pathologically, this condition manifests as elevated liver cell apoptosis and reduced lipid transport capacity, further exacerbating insulin resistance. Liver cell apoptosis and mitochondrial dysfunction are key pathological features of PCOS-associated liver diseases, contributing significantly to the progression of PCOS. Although zinc sulfate is recognized for its antioxidant properties, its efficacy in ameliorating PCOS-related liver damage remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Female Sprague-Dawley rats were induced with PCOS and non-alcoholic fatty liver disease (NAFLD) through a high-fat diet and letrozole administration over 28 days. Subsequently, the model rats received zinc sulfate treatment via gavage once daily for an additional 21 days. Serum hormone levels and biochemical markers were assessed using ELISA and enzymatic assays. Histological examination of ovarian and liver tissues was performed using hematoxylin and eosin (HE) staining, while hepatic lipid accumulation was evaluated by Oil Red O staining. Transmission electron microscopy was employed to examine liver cell ultrastructure, and TUNEL staining was used to assess hepatocellular apoptosis. Transcriptome sequencing was conducted on liver tissues to identify key genes and pathways, which were further validated by Western blotting and immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Initial blood sampling revealed decreased serum zinc concentration in the PCOS group, alongside elevated levels of testosterone (T), luteinizing hormone (LH), alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglycerides (TG), total cholesterol (TC), blood glucose, fasting insulin, and oral glucose tolerance test (OGTT) values. However, the levels of serum estrogen (E2) and follicle-stimulating hormone (FSH) in the PCOS group were significantly decreased. Markers of oxidative stress, including malondialdehyde (MDA), superoxide dismutase (SOD), glutathione disulfide\/glutathione ratio (GSSG\/GSH), glutathione peroxidase (GSH-PX), and catalase (CAT), were also increased. Zinc sulfate treatment effectively improved all these parameters. HE and Oil Red O staining confirmed that zinc sulfate mitigated high-fat diet and letrozole-induced fatty liver. Furthermore, zinc sulfate alleviated severe hepatocellular apoptosis and mitochondrial damage observed in PCOS rats. Transcriptomic analysis indicated that zinc sulfate primarily mitigated PCOS-related liver damage via the cholesterol synthesis pathway, and experimental validation demonstrated that zinc sulfate inhibited oxidative stress and apoptosis in liver cells through the NF-\u03baB pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrates that zinc sulfate ameliorates liver oxidative stress and apoptosis in PCOS by modulating the NF-\u03baB pathway, offering a novel therapeutic approach for managing PCOS-associated liver diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1569866","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:10:39Z","timestamp":1749168639000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Zinc sulfate improves insulin resistance, oxidative stress and apoptosis in liver tissues of PCOS rats through the NF-\u03baB pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Yi-fan","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087454","article-title":"Dysregulated liver metabolism and polycystic ovarian syndrome","volume":"24","author":"Khan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl Clin Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.488776","article-title":"Obesity and insulin resistance in women with polycystic ovary syndrome","volume":"27","author":"Chun-Sen","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00167","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome: unraveling the conundrum in skeletal muscle","volume":"104","author":"Stepto","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i3.129","article-title":"Markers of insulin resistance in Polycystic ovary syndrome women: An update","volume":"13","author":"Amisi","year":"2022","journal-title":"World J Diabetes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"108783","DOI":"10.1016\/j.isci.2024.108783","article-title":"Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome","volume":"27","author":"Xu","year":"2024","journal-title":"iScience"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000352","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"7","author":"Asfari","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: a narrative review","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism: Clin Exp"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86013","article-title":"Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance","volume":"126","author":"Petersen","year":"2016","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"115242","DOI":"10.1016\/j.bcp.2022.115242","article-title":"Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases","volume":"205","author":"Ma","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15813","article-title":"Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radical Biol Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-024-04085-9","article-title":"Association of plasma metal levels with outcomes of assisted reproduction in polycystic ovary syndrome","volume":"202","author":"Yin","year":"2024","journal-title":"Biol Trace element Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800463","article-title":"Zinc reduces hepatic lipid deposition and activates lipophagy via Zn(2+)\/MTF-1\/PPAR\u03b1 and Ca(2+)\/CaMKK\u03b2\/AMPK pathways","volume":"32","author":"Wei","year":"2018","journal-title":"FASEB J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.1996.10718608","article-title":"Zinc and growth","volume":"15","author":"Nishi","year":"1996","journal-title":"J Am Coll Nutr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.12659\/MSM.912341","article-title":"The flavanone, naringenin, modifies antioxidant and steroidogenic enzyme activity in a rat model of letrozole-induced polycystic ovary syndrome","volume":"25","author":"Hong","year":"2019","journal-title":"Med Sci monitor"},{"key":"B23","article-title":"Clinical study on the treatment of insulin resistance in polycystic ovary syndrome with spleen deficiency and phlegm-dampness with modified cangfu daotan decoction","volume-title":"Yunnan J Traditional Chinese Med Materia Medica","author":"Xinfang","year":"2024"},{"key":"B24","article-title":"Toxicity study of zinc compounds","author":"Ning","year":"1991","journal-title":"Chinese J Public Health"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J assisted Reprod Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatol (Baltimore Md)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010131","article-title":"Prevalence, risk factors, and pathophysiology of nonalcoholic fatty liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)","volume":"10","author":"Spremovi\u0107 Ra\u0111enovi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14279","article-title":"Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis","volume":"40","author":"Sarkar","year":"2020","journal-title":"Liver Int"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24477","article-title":"Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-022-01028-4","article-title":"Management of dyslipidemia in patients with non-alcoholic fatty liver disease","volume":"24","author":"Martin","year":"2022","journal-title":"Curr Atheroscl Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12876-021-02072-1","article-title":"Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrendo.2015.189","article-title":"Regulation of metabolism by the innate immune system","volume":"12","author":"Lackey","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1096\/fj.15-270496","article-title":"Activated Kupffer cells inhibit insulin sensitivity in obese mice","volume":"29","author":"Tencerova","year":"2015","journal-title":"FASEB J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-024-04261-x","article-title":"Association between serum zinc and non-alcoholic fatty liver disease and advanced liver fibrosis: NHANES 2011\u20132016","volume":"203","author":"Ye","year":"2024","journal-title":"Biol Trace element Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s40795-023-00776-z","article-title":"The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial","volume":"9","author":"Rezaei","year":"2023","journal-title":"BMC Nutr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306827","article-title":"CSN6-SPOP-HMGCS1 axis promotes hepatocellular carcinoma progression via YAP1 activation","volume":"11","author":"Li","year":"2024","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"102678","DOI":"10.1016\/j.jbc.2022.102678","article-title":"Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1","volume":"298","author":"Chen","year":"2022","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2928-y","article-title":"Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S219013","article-title":"Therapeutic targets of hypercholesterolemia: HMGCR and LDLR","volume":"12","author":"Ma","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"155774","DOI":"10.1016\/j.metabol.2023.155774","article-title":"Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPAR\u03b1-mediated CYP7A1 activation","volume":"152","author":"Chen","year":"2024","journal-title":"Metabolism: Clin Exp"},{"key":"B41","doi-asserted-by":"publisher","first-page":"115388","DOI":"10.1016\/j.taap.2020.115388","article-title":"Diosgenin alleviates hypercholesterolemia via SRB1\/CES-1\/CYP7A1\/FXR pathway in high-fat diet-fed rats","volume":"412","author":"Yu","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41420-024-01975-8","article-title":"TM7SF2-induced lipid reprogramming promotes cell proliferation and migration via CPT1A\/Wnt\/\u03b2-Catenin axis in cervical cancer cells","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Death Discovery"},{"key":"B43","doi-asserted-by":"publisher","first-page":"118897","DOI":"10.1016\/j.bbamcr.2020.118897","article-title":"Tm7sf2 gene promotes adipocyte differentiation of mouse embryonic fibroblasts and improves insulin sensitivity","volume":"1868","author":"Gatticchi","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"17478","DOI":"10.1038\/s41598-024-68585-3","article-title":"Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's disease","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"103200","DOI":"10.1016\/j.psj.2023.103200","article-title":"miR-19b-3p regulated by estrogen controls lipid synthesis through targeting MSMO1 and ELOVL5 in LMH cells","volume":"103","author":"Jia","year":"2024","journal-title":"Poult Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"103407","DOI":"10.1016\/j.redox.2024.103407","article-title":"Inhibition of KDM4A restricts SQLE transcription and induces oxidative stress imbalance to suppress bladder cancer","volume":"77","author":"Zhang","year":"2024","journal-title":"Redox Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202300515","article-title":"High plant protein diet ameliorated hepatic lipid accumulation through the modulation of gut microbiota","volume":"67","author":"Zhu","year":"2023","journal-title":"Mol Nutr Food Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/neup.2015.35.issue-5","article-title":"Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies","volume":"35","author":"Nakamura","year":"2015","journal-title":"Neuropathology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19437","article-title":"HUB genes transcriptionally regulate lipid metabolism in alveolar type II cells under LPS stimulation","volume":"9","author":"Chen","year":"2023","journal-title":"Heliyon"},{"key":"B50","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00125-022-05829-9","article-title":"Hepatic Acat2 overexpression promotes systemic cholesterol metabolism and adipose lipid metabolism in mice","volume":"66","author":"Ma","year":"2023","journal-title":"Diabetologia"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00477-X","article-title":"The phosphorylation status of nuclear NF-kappa B determines its association with CBP\/p300 or HDAC-1","volume":"9","author":"Zhong","year":"2002","journal-title":"Mol Cell"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S484531","article-title":"Semaglutide alleviates ovary inflammation via the AMPK\/SIRT1\/NF\u2212\u03baB signaling pathway in polycystic ovary syndrome mice","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.12170","article-title":"Osthole exhibits the remedial potential for polycystic ovary syndrome mice through Nrf2-Foxo1-GSH-NF-\u03baB pathway","volume":"48","author":"Jin","year":"2024","journal-title":"Cell Biol Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030856","article-title":"Non-alcoholic fatty liver disease in patients with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression","volume":"12","author":"Manzano-Nunez","year":"2023","journal-title":"J Clin Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1569866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:10:40Z","timestamp":1749168640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1569866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":58,"alternative-id":["10.3389\/fendo.2025.1569866"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1569866","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"article-number":"1569866"}}